10-Q: Huron Reports Strong Q3 Revenue Growth, Strategic Acquisitions Drive Expansion

Huron Consulting Group Inc. announced robust third-quarter revenue growth and increased adjusted earnings per share, fueled by strategic acquisitions and strong demand across all segments.

Summary

• Total revenues increased 16.7% to $441.3 million for the third quarter of 2025, up from $378.1 million in the third quarter of 2024.
• Revenues before reimbursable expenses grew 16.8% to $432.4 million in the third quarter of 2025, with 10.2% organic growth excluding acquisitions and the Studer Education divestiture.
• Net income for the third quarter of 2025 rose 12.0% to $30.4 million, resulting in diluted EPS of $1.71, a 16.3% increase.
• Adjusted diluted EPS for the third quarter of 2025 increased 25.0% to $2.10.
• For the nine months ended September 30, 2025, total revenues increased 12.0% to $1.26 billion.
• Nine-month net income decreased 10.0% to $74.4 million, primarily due to non-cash impairment charges on investments and a prior-year litigation settlement gain.
• Nine-month diluted EPS decreased to $4.13 from $4.43, impacted by the lower net income.
• Adjusted diluted EPS for the nine months increased 24.1% to $5.67.
• The company completed five acquisitions in 2025, adding $15.3 million and $17.8 million in revenues for the third quarter and nine months of 2025, respectively.
• Net cash provided by operating activities increased to $67.0 million for the nine months ended September 30, 2025.
• Long-term debt increased significantly to $589.6 million as of September 30, 2025, from $342.9 million at December 31, 2024, primarily due to funding acquisitions and share repurchases.
• A $11.1 million non-cash credit-related impairment charge was recognized on the convertible debt investment in Shorelight Holdings, LLC in the second quarter of 2025.
• An additional $5.0 million in non-cash impairment charges were recognized on an equity investment in a hospital-at-home company in the first nine months of 2025.
• The company repurchased $152.5 million of common stock (1,084,794 shares) in the first nine months of 2025.

Sentiment

Score: 7

Explanation: The company demonstrated strong operational performance with robust revenue growth and improved adjusted profitability, driven by successful strategic acquisitions and organic demand. However, the increase in debt to fund acquisitions and share repurchases, coupled with substantial non-cash impairment charges on long-term investments, introduces a degree of caution.

Positives

• Strong revenue growth in Q3 2025 (16.8% before reimbursable expenses) and 9M 2025 (12.1% before reimbursable expenses).
• Organic revenue growth of 10.2% in Q3 2025, excluding acquisitions and divestitures.
• Increased diluted EPS by 16.3% to $1.71 in Q3 2025.
• Adjusted diluted EPS grew significantly by 25.0% to $2.10 in Q3 2025 and 24.1% to $5.67 for 9M 2025.
• Adjusted EBITDA as a percentage of revenues before reimbursable expenses improved to 15.6% in Q3 2025 and 13.8% for 9M 2025.
• Healthcare segment operating income increased by $18.1 million (36.5%) in Q3 2025 and $36.1 million (24.5%) for 9M 2025, with improved operating margins.
• Education segment operating income increased by $4.1 million (14.0%) in Q3 2025 and $6.7 million (8.2%) for 9M 2025, with improved operating margins.
• Net cash provided by operating activities increased by $5.3 million to $67.0 million for the nine months ended September 30, 2025.
• Successful completion of five strategic acquisitions in 2025, expanding service offerings and market reach.
• Amended Credit Agreement provides a $700 million revolving credit facility and a $400 million term loan, enhancing financial flexibility.
• The company was in compliance with all financial covenants as of September 30, 2025, with a Consolidated Leverage Ratio of 2.30 to 1.00 and a Consolidated Interest Coverage Ratio of 8.86 to 1.00.
• Continued share repurchase program, with $152.5 million deployed in 9M 2025 and $112.6 million remaining available.

Negatives

• Net income for the nine months ended September 30, 2025, decreased by 10.0% to $74.4 million, primarily due to non-cash impairment charges and a prior-year litigation settlement gain.
• Diluted EPS for the nine months decreased to $4.13 from $4.43.
• Operating margin for the nine months decreased to 10.4% from 11.1%.
• Commercial segment operating income decreased by $2.5 million (15.4%) in Q3 2025 and $1.7 million (4.4%) for 9M 2025, with a notable decrease in operating margin to 16.4% from 24.5%.
• Significant non-cash credit-related impairment charge of $11.1 million on the convertible debt investment in Shorelight Holdings, LLC.
• Non-cash impairment charges of $5.0 million on the equity investment in a hospital-at-home company.
• Long-term debt increased substantially to $589.6 million from $342.9 million, leading to a higher Consolidated Leverage Ratio (2.30 to 1.00 from 1.39 to 1.00).
• Interest expense, net of interest income, increased by $4.2 million in Q3 2025 and $6.0 million for 9M 2025 due to higher borrowing levels and interest rates.
• Unallocated corporate expenses increased by $9.7 million (20.8%) in Q3 2025 and $19.8 million (13.8%) for 9M 2025, partly due to professional fees for acquisition activity.
• Accumulated other comprehensive income (loss) shifted from a gain of $11.886 million at Dec 31, 2024, to a loss of $(7.495) million at Sep 30, 2025, primarily due to unrealized losses on investments and cash flow hedges.

Risks

• Failure to achieve expected utilization rates, billing rates, and the necessary number of revenue-generating professionals.
• Inability to expand or adjust service offerings in response to market demands.
• Dependence on renewal of client-based services.
• Dependence on new business and retention of current clients and qualified personnel.
• Failure to maintain third-party provider relationships and strategic alliances.
• Inability to license technology to and from third parties.
• Impairment of goodwill, which increased significantly due to recent acquisitions.
• Various factors related to income and other taxes.
• Difficulties in successfully integrating acquired businesses and achieving expected benefits from such acquisitions.
• Risks relating to privacy, information security, and related laws and standards.
• General downturn or volatility in market conditions, including as a result of current global trade tensions and/or tariffs.
• Changes in the federal regulatory environment impacting investments, specifically noted for Shorelight Holdings, LLC.
• Exposure to changes in interest rates associated with variable-rate borrowings under the senior secured credit facility.
• Exposure to foreign currency exchange rate risks associated with operations in India and Canada.

Future Outlook

The company expects to sustain accelerated growth in Healthcare and Education, grow businesses in Commercial industries, and expand its global digital capability. It aims for margin expansion through improved operational efficiency, increased utilization, pricing realization initiatives, and scaling selling, general, and administrative expenses. The company plans to deploy capital strategically, including returning capital to shareholders and executing strategic tuck-in acquisitions. Estimated cash utilization for property and equipment and software development in 2025 is $30 million to $35 million. The adoption of new accounting standards (ASU 2023-09, ASU 2024-03, ASU 2025-05, ASU 2025-06) is not expected to impact financial position or results of operations, but will result in additional disclosures.

Management Comments

• The overall increase in revenues before reimbursable expenses reflects strengthened demand for our Consulting and Managed Services capabilities and our Digital capabilities across all segments.
• We proactively plan and manage the size and composition of our workforce and take actions as needed to address changes in the anticipated demand for our services as employee compensation costs are the most significant portion of our operating expenses.
• We believe our internally generated liquidity, together with our available cash, and the borrowing capacity available under our senior secured credit facility will be adequate to support our current financing needs and long-term growth strategy.

Industry Context

Huron operates in the professional services sector, serving healthcare, education, and commercial industries. The firm is adapting to competitive, regulatory, financial, and broader market changes, particularly in healthcare and education. The focus on digital offerings, including enterprise health record (EHR), enterprise resource planning (ERP), enterprise performance management (EPM), customer relationship management (CRM), data management, artificial intelligence (AI), and automation, aligns with broader industry trends of digital transformation and data-driven decision-making. The acquisition strategy, particularly in financial services (Treliant) and strategy/operations consulting (WP&C), indicates a move to bolster capabilities in industries facing significant disruption and regulatory change. The credit-related impairment on Shorelight Holdings, LLC, reflects challenges in the federal regulatory environment for international student access and retention.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or projects to benchmark against, focusing instead on internal performance metrics.
• The increase in adjusted EBITDA margin (15.6% in Q3 2025 vs 14.8% in Q3 2024) suggests improved operational efficiency, which is a positive trend in the consulting industry.
• The significant increase in long-term debt and leverage ratio, while within covenant limits, could be higher than some industry peers, especially given the non-cash impairment charges on investments.
• The strong organic growth (10.2% in Q3 2025) is competitive within the consulting sector, indicating healthy demand for services.

Corporate Governance

Legal Proceedings

• No party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on financial position or results of operations as of the filing date.
• In Q2 2024, recognized a pre-tax $15.0 million litigation settlement gain related to a completed legal matter where Huron was the plaintiff.

Stakeholder Impact

• Shareholders: Positive impact from increased adjusted EPS and ongoing share repurchase program. Negative impact from decreased GAAP net income and diluted EPS for the nine-month period, and the decrease in total stockholders' equity.
• Employees: Increased headcount (15.2% for revenue-generating professionals, 55.5% for Managed Services professionals) indicates growth and job opportunities. Compensation costs increased due to headcount and salary increases.
• Clients: Strengthened demand for consulting and digital services across all segments, enhanced offerings through acquisitions, suggesting improved service capabilities.
• Creditors: Increased long-term debt, but the company remains in compliance with financial covenants under the new credit facility.

Next Steps

• Finalize valuations for Treliant and WP&C acquisitions within one year from their respective acquisition dates.
• Continue to evaluate the impact of new accounting standards (ASU 2025-05, ASU 2025-06) on consolidated financial statements.
• Management will continue to determine the amount and timing of share repurchases under the remaining $112.6 million authorization.
• Estimated cash utilization for property and equipment and software development in 2025 is $30 million to $35 million.
• Monitor the federal regulatory environment impacting the Shorelight Holdings, LLC investment.

Key Dates

Recommendation

While Huron demonstrated strong operational performance with robust revenue growth and improved adjusted earnings, the significant increase in debt to fund acquisitions and share repurchases, coupled with substantial non-cash impairment charges on long-term investments, introduces a degree of caution. The increase in the leverage ratio, though within covenants, warrants monitoring. The company's strategic direction and market demand are positive, but the financial structure changes and investment write-downs suggest a 'hold' position until there's clearer evidence of successful integration of acquisitions and stabilization of investment valuations.

Keywords

Consulting, Professional Services, Healthcare, Education, Commercial, Digital Transformation, Acquisitions, Financial Performance, Revenue Cycle, Strategy, Operations, Managed Services, Share Repurchase, Debt, Impairment, SEC Filing, 10-Q